Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary Intervention
Ehtisham Mahmud(Cardiovascular Institute of the South), Anthony N. DeMaria(University of California System), Shahin Keramati(University of California San Diego), William F. Penny(VA San Diego Healthcare System), Lawrence Ang(University of California San Diego), Jeffrey J. Cavendish(Naval Medical Center San Diego), Vachaspathi Palakodeti(University of California San Diego), Sotirios Tsimikas(Brigham and Women's Hospital), Guilherme Bromberg‐Marin(University of California San Diego), Cuong V. Nguyen(University of California San Diego), Guido Schnyder(University of California San Diego)
Cited by 20
Related Papers
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837
Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease.
|Circulation|1991|666
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
|New England Journal of Medicine|2019|663
Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses
|Cell|2012|598
Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure
|Journal of the American College of Cardiology|1994|429